Skip to main content
Equibles

NORTHERN TRUST CORP

Bank

Position in ATOS — Atossa Therapeutics, Inc.

CIK 73124 CHICAGO, IL
Back to ATOS Full portfolio

Position in ATOS

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$39,080
-$62,038 QoQ
Shares Held
20,249
+5.3% QoQ
Ownership
0.203%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#11
of 31 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ATOS Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

NORTHERN TRUST CORP holds $7,872,952,300 across 424 Biotechnology names. ATOS ranks #387 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 2,486,478 $1,235,108,212
2 REGN
Regeneron Pharmaceuticals, Inc.
 916,467 $571,453,829
3 ALNY
Alnylam Pharmaceuticals, Inc.
 886,900 $266,983,504
4 RPRX
Royalty Pharma plc
 4,718,859 $264,586,419
5 RVMD
Revolution Medicines, Inc.
 1,117,110 $209,212,357
6 MRNA
Moderna, Inc.
 2,985,329 $209,062,587
7 INCY
Incyte Corp
 1,761,966 $199,736,460
8 CYTK
Cytokinetics Inc
 1,647,345 $140,337,319

All Filings in ATOS

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $39,080 20,249
2026-03-31 $101,118 19,224
2025-12-31 $170,155 288,399
2025-09-30 $229,137 263,377
2025-06-30 $218,602 263,377
2025-03-31 $652,578 973,998
2024-12-31 $964,180 1,025,724
2024-09-30 $1,450,381 954,199
2024-06-30 $317,977 267,208
2024-03-31 $406,209 225,672
2023-12-31 $200,571 227,922
2023-09-30 $158,835 214,642
2023-06-30 $270,448 214,642
2023-03-31 $155,142 215,476
2022-12-31 $116,729 220,244
2022-09-30 $182,801 220,244
2022-06-30 $238,665 218,959
2022-03-31 $1,258,687 1,006,950
2021-12-31 $1,679,179 1,049,488
2021-09-30 $3,529,008 1,082,518
2021-06-30 $7,102,743 1,123,852
2021-03-31 $307,317 145,648
2020-12-31 $10,184 10,721
2020-09-30 $25,944 10,721
2020-06-30 $40,739 10,721
2020-03-31 $16,663 12,529